The high-end pharmaceutical equipment market has broad prospects, and the domestic alternative space needs to be tapped urgently

[ Market Analysis of Chemical Machinery Equipment Network ] Recently, it was reported that new equipment such as fluidized beds are being installed in the production workshop of a pharmaceutical company.
It is reported that the new equipment is imported equipment purchased by the company, the purpose is to promote the production of high-end pharmaceutical preparations, and continue to expand capacity
.
The workshop is also part of the company's high-end intelligent processing and manufacturing center project, with an estimated total investment of nearly 700 million yuan.
After completion, it is expected to help pharmaceutical companies achieve stable production and overproduction, and improve production efficiency
.

In the pharmaceutical industry, in recent years, with the promotion of policies such as consistency evaluation and centralized drug procurement, the pharmaceutical industry has been continuously upgraded, and the profits of pharmaceutical companies have been under pressure.
In addition, the rising costs have forced pharmaceutical companies to increase innovation and control costs.
, improve production capacity, thereby enhancing market competitiveness
.

 

At present, informatization, integration and intelligence are becoming the new development direction of the pharmaceutical industry.
As the "mother machine" of drug production, pharmaceutical equipment is also facing the challenge of upgrading
.
At present, China's pharmaceutical equipment is mainly concentrated in low-end fields, which can basically meet the small-scale production needs of domestic pharmaceutical companies
.
However, in the high-end field, the high-end equipment used by pharmaceutical companies is mainly imported products, and the number of domestic high-end pharmaceutical machine companies is small, and there are also few products with competitive capabilities, which cannot meet the needs of pharmaceutical companies to stabilize and exceed production and improve production efficiency
.

 

　　High-end equipment is the premise and key to the development of the manufacturing industry.
Vigorously developing high-end pharmaceutical machine equipment is also the only way to improve the level of China's pharmaceutical machine manufacturing industry and narrow the gap with imported equipment
.
In the high-end field of equipment manufacturing industry, it is mainly reflected in three aspects: first, high technology content; second, high value-added characteristics; third, occupying the core part of the industrial chain, and its development level determines the overall competitiveness of the industrial chain
.
Therefore, in the process of exploring high-end fields, domestic pharmaceutical machines need to move closer to these three aspects
.

 

　　In order to promote the development of China's high-end equipment manufacturing industry, relevant departments have also attached great importance to it
.
For example, in terms of R&D investment, the R&D investment in high-tech manufacturing and equipment manufacturing has continued to increase
.
The data shows that in 2019, the country invested a total of 2,214.
36 billion yuan in research and experimental development (R&D), an increase of 246.
57 billion yuan or 12.
5% ​​over the previous year; in terms of policy support, the 14th Five-Year Plan and the 2035 long-term goal proposal It is mentioned that a number of major scientific and technological research projects will be deployed in key areas and key links such as high-end equipment manufacturing, and efforts will be made to overcome a number of key core technologies and "stuck neck" technologies, and accelerate the localization and replacement of key components
.

 

　　With the advancement of a series of policies to encourage the development of high-end equipment manufacturing industry and the changes in the needs and requirements of pharmaceutical companies under the new situation, it is expected that the market demand for medium and high-end pharmaceutical equipment in China will maintain rapid growth
.
The research report previously released by Industrial Securities mentioned that the pharmaceutical equipment market has entered a growth period of overall stability and partial breakthroughs: with the recovery of the upstream pharmaceutical industry, China's pharmaceutical equipment market is expected to reach US$4.
58 billion in 2025, with a compound growth rate of 8.
1%
.

 

　　In general, the domestic mid-to-high-end pharmaceutical equipment market has huge development opportunities.
Domestic pharmaceutical machine companies should seize the development opportunity, continue to tackle key problems, break the bottleneck of "stuck neck", speed up the pace of domestic substitution, and better help China's pharmaceutical industry.
high-quality development
.

 

　　The industry pointed out that the production of intelligent medicine machine equipment is an important part of the strategic emerging industry, and it has a large development space and potential in the high-end equipment manufacturing of the medicine machine industry
.
The production of intelligent medicine machine equipment can, on the one hand, be transformed and upgraded to traditional pharmaceutical companies, and on the other hand, it can also satisfy downstream pharmaceutical companies’ response to new pharmaceutical regulations and policies
.
The person believes that intelligent pharmaceutical equipment has broad development prospects in the future, and pharmaceutical machine companies should increase their research and development efforts in this field, and regard it as one of the key directions of enterprise research and development, and use automation to drive intelligence.
Deadlock in the development of the industry
.

 

　　Original title: The high-end pharmaceutical equipment market has broad prospects, and the domestic alternative space needs to be tapped urgently